
A clinical trial to test pregnant women for Group B Strep (GBS) – the most common cause of life-threatening infection in newborn babies – will fail unless the Government intervenes, experts have warned.
Some 80 hospitals are needed for the trial to go ahead but only 32 have committed to it, with a deadline for registering of September.